886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity

التفاصيل البيبلوغرافية
العنوان: 886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity
المؤلفون: Yong Moon, Mithun Gosh, Hee-Jung An, Tae Hoen Kim, Sa Deok Hong, Nar Bahadur Katuwal, Minsil Kang
المصدر: Regular and Young Investigator Award Abstracts.
بيانات النشر: BMJ Publishing Group Ltd, 2022.
سنة النشر: 2022
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::321d7445d803536eb8a88fae25258461
https://doi.org/10.1136/jitc-2022-sitc2022.0886
رقم الأكسشن: edsair.doi...........321d7445d803536eb8a88fae25258461
قاعدة البيانات: OpenAIRE